Publication | Closed Access

Dexmedetomidine attenuates lipopolysaccharide-induced liver oxidative stress and cell apoptosis in rats by increasing GSK-3β/MKP-1/Nrf2 pathway activity via the α2 adrenergic receptor

InflammationMolecular PharmacologyBiochemistryCell ApoptosisLiver PhysiologyPhysiologyα2 Adrenergic ReceptorMedicineCell DeathExperimental PharmacologyPharmacotherapyHepatotoxicityPharmacologyDrug-induced Liver InjuryOxidative StressHealth Sciences